<unk>  is an immunological agent that is FDA approved for the treatment of patients with relapsing forms of multiple sclerosis.   Common adverse reactions include injection site erythema, influenza-like illness, pyrexia, headache, myalgia, chills, injection site pain, asthenia, injection site pruritus, and arthralgia.
Peginterferon Beta-1a
Interferon Alfa-n3
Interferon alfa-2b
Interferon alfa-2a
Interferon type I
Pegylated interferon alpha
Pegylated interferon-alpha-2a
Pegylated interferon alfa-2a